Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report) shares gapped down before the market opened on Friday. The stock had previously closed at $8.56, but opened at $8.28. Curaleaf shares last traded at $8.20, with a volume of 30,816 shares changing hands.
Analyst Ratings Changes
CURLF has been the subject of a number of recent analyst reports. Citigroup reissued a “buy” rating on shares of Curaleaf in a research report on Thursday, August 6th. Zacks Research lowered Curaleaf from a “strong-buy” rating to a “hold” rating in a research report on Tuesday. Finally, UBS Group set a $6.00 price target on Curaleaf in a research note on Monday, October 5th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $6.00.
Read Our Latest Analysis on Curaleaf
Curaleaf Stock Performance
The company has a market cap of $1.88 billion, a PE ratio of -61.79 and a beta of 1.55. The company has a current ratio of 1.52, a quick ratio of 0.73 and a debt-to-equity ratio of 1.06. The firm’s 50-day simple moving average is $9.89 and its two-hundred day simple moving average is $8.69.
Curaleaf (OTCMKTS:CURLF – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.25. The business had revenue of $340.10 million for the quarter, compared to analyst estimates of $332.00 million. Curaleaf had a negative net margin of 2.62% and a negative return on equity of 0.88%. As a group, research analysts anticipate that Curaleaf Holdings, Inc. will post 0.01 earnings per share for the current fiscal year.
Curaleaf Company Profile
Curaleaf Holdings, Inc is a cannabis company that cultivates, processes, manufactures and sells cannabis products. Through its retail dispensaries and wholesale operations, the company offers flower, pre-rolls, vaporizers, edibles, concentrates, tinctures and other cannabis-derived products for medical and adult-use markets, where permitted by law.
Curaleaf markets products under brands that include Curaleaf, Select and Grassroots. Its business is primarily focused on the United States, where it operates a network of cultivation and processing facilities, dispensaries and distribution operations across multiple state-regulated cannabis markets.
Read More
- Five stocks we like better than Curaleaf
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
- Palantir’s Potential Next Catalyst After Retail Profit-Taking
- Morgan Stanley Beats on Earnings, But Shares Fall on Trading Mix
- RTX Locks In a Decade of Defense Dominance
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
